{"id":11066,"date":"2020-09-30T20:26:11","date_gmt":"2020-10-01T00:26:11","guid":{"rendered":"http:\/\/drupal.test\/projects\/vers-une-mise-en-oeuvre-clinique-de-la-pharmacogenomique-pour-ameliorer-le-traitement-des-personnes\/"},"modified":"2022-07-26T11:24:16","modified_gmt":"2022-07-26T15:24:16","slug":"vers-une-mise-en-oeuvre-clinique-de-la-pharmacogenomique-pour-ameliorer-le-traitement-des-personnes","status":"publish","type":"project","link":"https:\/\/genomecanada.ca\/fr\/project\/vers-une-mise-en-oeuvre-clinique-de-la-pharmacogenomique-pour-ameliorer-le-traitement-des-personnes\/","title":{"rendered":"Vers une mise en \u0153uvre clinique de la pharmacog\u00e9nomique pour am\u00e9liorer le traitement des personnes souffrant de d\u00e9pression en Colombie-Britannique"},"content":{"rendered":"<p>Les probl\u00e8mes de sant\u00e9 mentale sont tr\u00e8s fr\u00e9quents. En 2015, on a estim\u00e9 que plus de 300\u00a0millions de personnes dans le monde souffraient de d\u00e9pression et qu\u2019au Canada, plus d\u2019une personne sur dix sera atteinte d\u2019une forme majeure de d\u00e9pression \u00e0 un moment ou \u00e0 un autre de sa vie. Il existe de nombreux traitements efficaces de la maladie mentale, notamment les th\u00e9rapies bas\u00e9es sur la parole et les m\u00e9dicaments. Actuellement, en Colombie-Britannique, il est courant de recourir \u00e0 la pharmacoth\u00e9rapie. Les choix de m\u00e9dicaments comprennent toute une gamme d\u2019antid\u00e9presseurs. Chez les personnes souffrant de probl\u00e8mes de sant\u00e9 mentale, on proc\u00e8de souvent par t\u00e2tonnements pour trouver un m\u00e9dicament \u00e0 la fois efficace et d\u00e9nu\u00e9 d\u2019effets secondaires graves. On pense que la composition g\u00e9n\u00e9tique d\u2019un individu intervient dans l\u2019efficacit\u00e9 et la manifestation des effets secondaires des m\u00e9dicaments.  Les tests \u00ab\u00a0pharmacog\u00e9nomiques\u00a0\u00bb (c\u2019est-\u00e0-dire la v\u00e9rification de l\u2019ad\u00e9quation de la constitution g\u00e9n\u00e9tique du patient par rapport au m\u00e9dicament en question) constituent une approche nouvelle et prometteuse. Dans cette \u00e9tude, nous v\u00e9rifierons si de tels tests devraient \u00eatre utilis\u00e9s de fa\u00e7on syst\u00e9matique en Colombie-Britannique. Nous \u00e9tablirons dans quelle mesure les patients pourraient voir leur sant\u00e9 s\u2019am\u00e9liorer et si les tests pr\u00e9sentent un bon rapport qualit\u00e9-prix pour le syst\u00e8me de sant\u00e9. Pour y parvenir, nous avons cr\u00e9\u00e9 une \u00e9quipe compos\u00e9e de personnes ayant des ant\u00e9c\u00e9dents et des comp\u00e9tences tr\u00e8s diff\u00e9rents et qui sont int\u00e9ress\u00e9es \u00e0 travailler ensemble. Une partie passionnante du projet est que nous aurons au moins deux patients atteints de probl\u00e8mes de sant\u00e9 mentale dans notre \u00e9quipe et qui travailleront avec nous dans tous les volets du projet. Notre travail consistera \u00e0 passer en revue les recherches que d\u2019autres ont d\u00e9j\u00e0 effectu\u00e9es pour que nous puissions tirer des enseignements d\u2019\u00e9tudes existantes. Nous parlerons \u00e9galement aux patients, aux m\u00e9decins, aux infirmi\u00e8res, aux pharmaciens, aux conseillers et aux autres personnes qui s\u2019occupent des patients souffrant de troubles mentaux en Colombie-Britannique. Tous ces renseignements r\u00e9unis nous permettront de d\u00e9crire les exp\u00e9riences types des patients. \u00c0 \u2019aide d\u2019un \u00ab\u00a0mod\u00e8le de simulation\u00a0\u00bb, nous pourrons \u00e9tablir les avantages pour la sant\u00e9 des patients et les co\u00fbts, pour le syst\u00e8me, d\u2019un changement de pratique qui inclut l\u2019utilisation syst\u00e9matique de tests \u00ab\u00a0pharmacog\u00e9nomiques\u00a0\u00bb. Si nous constatons que les tests pharmacog\u00e9nomiques sont bons pour les patients et le syst\u00e8me de sant\u00e9, il deviendrait possible de modifier la prestation du traitement de la d\u00e9pression en Colombie-Britannique. Le principal avantage serait de prescrire des m\u00e9dicaments aux patients uniquement lorsqu\u2019il y a de fortes chances que ces m\u00e9dicaments fonctionnent et qu\u2019ils ne provoquent pas d\u2019effets secondaires.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Les probl\u00e8mes de sant\u00e9 mentale sont tr\u00e8s fr\u00e9quents. En 2015, on a estim\u00e9 que plus de 300\u00a0millions de personnes dans le monde souffraient de d\u00e9pression et qu\u2019au Canada, plus d\u2019une personne sur dix sera atteinte d\u2019une forme majeure de d\u00e9pression \u00e0 un moment ou \u00e0 un autre de sa vie. Il existe de nombreux traitements [&hellip;]<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"project-categories":[],"genome-competitions":[221],"project-sector":[],"genome_centres":[105],"class_list":["post-11066","project","type-project","status-publish","hentry","genome-competitions-programme-de-partenariats-pour-les-priorites-regionales-p3r","genome_centres-genome-british-columbia-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vers une mise en \u0153uvre clinique de la pharmacog\u00e9nomique pour am\u00e9liorer le traitement des personnes souffrant de d\u00e9pression en Colombie-Britannique - GenomeCanada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genomecanada.ca\/fr\/project\/vers-une-mise-en-oeuvre-clinique-de-la-pharmacogenomique-pour-ameliorer-le-traitement-des-personnes\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vers une mise en \u0153uvre clinique de la pharmacog\u00e9nomique pour am\u00e9liorer le traitement des personnes souffrant de d\u00e9pression en Colombie-Britannique - GenomeCanada\" \/>\n<meta property=\"og:description\" content=\"Les probl\u00e8mes de sant\u00e9 mentale sont tr\u00e8s fr\u00e9quents. En 2015, on a estim\u00e9 que plus de 300\u00a0millions de personnes dans le monde souffraient de d\u00e9pression et qu\u2019au Canada, plus d\u2019une personne sur dix sera atteinte d\u2019une forme majeure de d\u00e9pression \u00e0 un moment ou \u00e0 un autre de sa vie. Il existe de nombreux traitements [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genomecanada.ca\/fr\/project\/vers-une-mise-en-oeuvre-clinique-de-la-pharmacogenomique-pour-ameliorer-le-traitement-des-personnes\/\" \/>\n<meta property=\"og:site_name\" content=\"GenomeCanada\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-26T15:24:16+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/vers-une-mise-en-oeuvre-clinique-de-la-pharmacogenomique-pour-ameliorer-le-traitement-des-personnes\\\/\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/vers-une-mise-en-oeuvre-clinique-de-la-pharmacogenomique-pour-ameliorer-le-traitement-des-personnes\\\/\",\"name\":\"Vers une mise en \u0153uvre clinique de la pharmacog\u00e9nomique pour am\u00e9liorer le traitement des personnes souffrant de d\u00e9pression en Colombie-Britannique - GenomeCanada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#website\"},\"datePublished\":\"2020-10-01T00:26:11+00:00\",\"dateModified\":\"2022-07-26T15:24:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/vers-une-mise-en-oeuvre-clinique-de-la-pharmacogenomique-pour-ameliorer-le-traitement-des-personnes\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/vers-une-mise-en-oeuvre-clinique-de-la-pharmacogenomique-pour-ameliorer-le-traitement-des-personnes\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/vers-une-mise-en-oeuvre-clinique-de-la-pharmacogenomique-pour-ameliorer-le-traitement-des-personnes\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vers une mise en \u0153uvre clinique de la pharmacog\u00e9nomique pour am\u00e9liorer le traitement des personnes souffrant de d\u00e9pression en Colombie-Britannique\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\",\"name\":\"GenomeCanada\",\"description\":\"Harnessing the transformative power of genomics\",\"publisher\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#organization\",\"name\":\"GenomeCanada\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/genome-canada_stacked.svg\",\"contentUrl\":\"https:\\\/\\\/genomecanada.ca\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/genome-canada_stacked.svg\",\"width\":285,\"height\":180,\"caption\":\"GenomeCanada\"},\"image\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vers une mise en \u0153uvre clinique de la pharmacog\u00e9nomique pour am\u00e9liorer le traitement des personnes souffrant de d\u00e9pression en Colombie-Britannique - GenomeCanada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genomecanada.ca\/fr\/project\/vers-une-mise-en-oeuvre-clinique-de-la-pharmacogenomique-pour-ameliorer-le-traitement-des-personnes\/","og_locale":"fr_FR","og_type":"article","og_title":"Vers une mise en \u0153uvre clinique de la pharmacog\u00e9nomique pour am\u00e9liorer le traitement des personnes souffrant de d\u00e9pression en Colombie-Britannique - GenomeCanada","og_description":"Les probl\u00e8mes de sant\u00e9 mentale sont tr\u00e8s fr\u00e9quents. En 2015, on a estim\u00e9 que plus de 300\u00a0millions de personnes dans le monde souffraient de d\u00e9pression et qu\u2019au Canada, plus d\u2019une personne sur dix sera atteinte d\u2019une forme majeure de d\u00e9pression \u00e0 un moment ou \u00e0 un autre de sa vie. Il existe de nombreux traitements [&hellip;]","og_url":"https:\/\/genomecanada.ca\/fr\/project\/vers-une-mise-en-oeuvre-clinique-de-la-pharmacogenomique-pour-ameliorer-le-traitement-des-personnes\/","og_site_name":"GenomeCanada","article_modified_time":"2022-07-26T15:24:16+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/genomecanada.ca\/fr\/project\/vers-une-mise-en-oeuvre-clinique-de-la-pharmacogenomique-pour-ameliorer-le-traitement-des-personnes\/","url":"https:\/\/genomecanada.ca\/fr\/project\/vers-une-mise-en-oeuvre-clinique-de-la-pharmacogenomique-pour-ameliorer-le-traitement-des-personnes\/","name":"Vers une mise en \u0153uvre clinique de la pharmacog\u00e9nomique pour am\u00e9liorer le traitement des personnes souffrant de d\u00e9pression en Colombie-Britannique - GenomeCanada","isPartOf":{"@id":"https:\/\/genomecanada.ca\/fr\/#website"},"datePublished":"2020-10-01T00:26:11+00:00","dateModified":"2022-07-26T15:24:16+00:00","breadcrumb":{"@id":"https:\/\/genomecanada.ca\/fr\/project\/vers-une-mise-en-oeuvre-clinique-de-la-pharmacogenomique-pour-ameliorer-le-traitement-des-personnes\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genomecanada.ca\/fr\/project\/vers-une-mise-en-oeuvre-clinique-de-la-pharmacogenomique-pour-ameliorer-le-traitement-des-personnes\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/genomecanada.ca\/fr\/project\/vers-une-mise-en-oeuvre-clinique-de-la-pharmacogenomique-pour-ameliorer-le-traitement-des-personnes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/genomecanada.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Vers une mise en \u0153uvre clinique de la pharmacog\u00e9nomique pour am\u00e9liorer le traitement des personnes souffrant de d\u00e9pression en Colombie-Britannique"}]},{"@type":"WebSite","@id":"https:\/\/genomecanada.ca\/fr\/#website","url":"https:\/\/genomecanada.ca\/fr\/","name":"GenomeCanada","description":"Harnessing the transformative power of genomics","publisher":{"@id":"https:\/\/genomecanada.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genomecanada.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/genomecanada.ca\/fr\/#organization","name":"GenomeCanada","url":"https:\/\/genomecanada.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/genomecanada.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/genomecanada.ca\/wp-content\/uploads\/2021\/07\/genome-canada_stacked.svg","contentUrl":"https:\/\/genomecanada.ca\/wp-content\/uploads\/2021\/07\/genome-canada_stacked.svg","width":285,"height":180,"caption":"GenomeCanada"},"image":{"@id":"https:\/\/genomecanada.ca\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project\/11066","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/types\/project"}],"version-history":[{"count":0,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project\/11066\/revisions"}],"wp:attachment":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/media?parent=11066"}],"wp:term":[{"taxonomy":"project-categories","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project-categories?post=11066"},{"taxonomy":"genome-competitions","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/genome-competitions?post=11066"},{"taxonomy":"project-sector","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project-sector?post=11066"},{"taxonomy":"genome_centres","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/genome_centres?post=11066"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}